Bridging the Chasm Between Scientific Discovery and a Pivotal Clinical Trial for a CNS Disorder: A Checklist
Bibliographic record
Abstract
The central nervous system (CNS) is difficult to treat effectively after damage, whether the situation is congenital, traumatic, or degenerative. The effective translation of a novel preclinical discovery to a clinically meaningful human treatment is demanding and initially governed by fundamental achievements at the preclinical development level. Good laboratory practices (GLPs) are increasingly being adopted, as they provide all neurological investigators with increased confidence for the results. GLPs are demanding and ask scientists to adhere to many of the demanding criteria intrinsic to human studies. The subsequent preclinical development of a therapeutic is equally important and outlines the safety, dose, fate, window of opportunity, and route of administration. Human trials are channeled by established guidelines, but CNS clinical studies involve target populations that are heterogeneous and often rely on subjective (ordinal) outcome tools that can be questioned for their ability to accurately and sensitively discern subtle treatment effects. Improved solutions for the following concerns are evolving quickly: What is the most appropriate type of participant to enroll in each phase of a trial program? What would be the most accurate, sensitive, and reliable outcome measure for the chosen clinical target? How is a clinical endpoint threshold selected to determine whether the therapeutic provides a meaningful clinical benefit?
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.029 | 0.050 |
| Meta-epidemiology (narrow) | 0.002 | 0.001 |
| Meta-epidemiology (broad) | 0.002 | 0.001 |
| Bibliometrics | 0.005 | 0.004 |
| Science and technology studies | 0.002 | 0.007 |
| Scholarly communication | 0.008 | 0.014 |
| Open science | 0.004 | 0.005 |
| Research integrity | 0.006 | 0.015 |
| Insufficient payload (model declined to judge) | 0.015 | 0.010 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".